| Carella, Angelo Michele |
| Active, not recruiting | 3 | 249 | Europe, Japan, US, RoW | mocravimod | Priothera SAS, Priothera S.A.S. | Adult Acute Myeloid Leukemia | 11/25 | 11/25 | | |
GITMO-PHYLOS, NCT03270748: Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies |
|
|
| Completed | 2 | 78 | Europe | GvHD prophylaxis | Gruppo Italiano Trapianto di Midollo Osseo | Myeloid Malignancies | 11/22 | 11/22 | | |
| Active, not recruiting | 2 | 100 | Europe | Venetoclax and Decitabine | Gruppo Italiano Trapianto di Midollo Osseo, Abbvie, Janssen | Acute Myeloid Leukemia | 02/23 | 06/25 | | |
NCT06682637: Melflufen for Elderly Patients With Relapsed Myeloma |
|
|
| Not yet recruiting | 2 | 30 | Europe | Melflufen, Dexamethasone | Fondazione EMN Italy Onlus | Relapse Multiple Myeloma | 02/27 | 08/27 | | |
CLL2423, NCT05803395: Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy. |
|
|
| Recruiting | N/A | 954 | Europe | | Gruppo Italiano Malattie EMatologiche dell'Adulto, Fondazione Italiana Linfomi | Chronic Lymphocytic Leukemia, Indolent B-Cell Non-Hodgkin Lymphoma, COVID-19 | 09/24 | 09/24 | | |
| Not yet recruiting | N/A | 100 | Europe | | Gruppo Italiano Malattie EMatologiche dell'Adulto | VEXAS | 02/25 | 06/25 | | |
| Shimoni, Avichai |
| Active, not recruiting | 3 | 249 | Europe, Japan, US, RoW | mocravimod | Priothera SAS, Priothera S.A.S. | Adult Acute Myeloid Leukemia | 11/25 | 11/25 | | |
| Terruzzi, Elisabetta |
| Active, not recruiting | 3 | 249 | Europe, Japan, US, RoW | mocravimod | Priothera SAS, Priothera S.A.S. | Adult Acute Myeloid Leukemia | 11/25 | 11/25 | | |
GITMO-PHYLOS, NCT03270748: Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies |
|
|
| Completed | 2 | 78 | Europe | GvHD prophylaxis | Gruppo Italiano Trapianto di Midollo Osseo | Myeloid Malignancies | 11/22 | 11/22 | | |
| Active, not recruiting | 2 | 100 | Europe | Venetoclax and Decitabine | Gruppo Italiano Trapianto di Midollo Osseo, Abbvie, Janssen | Acute Myeloid Leukemia | 02/23 | 06/25 | | |
| Ram, Ron |
| Active, not recruiting | 3 | 249 | Europe, Japan, US, RoW | mocravimod | Priothera SAS, Priothera S.A.S. | Adult Acute Myeloid Leukemia | 11/25 | 11/25 | | |
NCT05286164: Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART |
|
|
| Recruiting | 2 | 30 | RoW | Eltrombopag | Tel-Aviv Sourasky Medical Center, Novartis | CART Treatment, B Cell Lymphoma | 04/23 | 04/24 | | |
NCT05385263: Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion |
|
|
| Recruiting | 2 | 20 | RoW | Nivolumab Injection [Opdivo] | Tel-Aviv Sourasky Medical Center | B Cell Lymphoma | 04/24 | 10/24 | | |
NCT04724642: COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency |
|
|
| Recruiting | N/A | 110 | RoW | | Tel-Aviv Sourasky Medical Center | Allogenic Hematopoietic Cell Transplant, CAR-T Therapy, Primary Immunodeficiency | 05/21 | 12/21 | | |
| Polverelli, Nicola |
| Active, not recruiting | 3 | 249 | Europe, Japan, US, RoW | mocravimod | Priothera SAS, Priothera S.A.S. | Adult Acute Myeloid Leukemia | 11/25 | 11/25 | | |
| Completed | N/A | 1150 | Europe | | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Polycythemia Vera | 12/23 | 12/23 | | |
NCT05553873: Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study. |
|
|
| Recruiting | N/A | 500 | Europe | | University of Milano Bicocca | Myeloproliferative Disease, Inflammatory Markers | 12/26 | 12/26 | | |
| Zuckermann, Tsila |
| Active, not recruiting | 3 | 249 | Europe, Japan, US, RoW | mocravimod | Priothera SAS, Priothera S.A.S. | Adult Acute Myeloid Leukemia | 11/25 | 11/25 | | |
